Access the full text.
Sign up today, get DeepDyve free for 14 days.
Nobuko Suefuji, D. Niino, F. Arakawa, K. Karube, Yoshizo Kimura, J. Kiyasu, M. Takeuchi, H. Miyoshi, Maki Yoshida, Ayako Ichikawa, Y. Sugita, K. Ohshima (2012)
Clinicopathological analysis of a composite lymphoma containing both T‐ and B‐cell lymphomasPathology International, 62
M. Federico, T. Rudiger, M. Bellei, B. Nathwani, S. Luminari, B. Coiffier, N. Harris, E. Jaffe, S. Pileri, K. Savage, D. Weisenburger, J. Armitage, N. Mounier, J. Vose (2013)
Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31 2
A. Attygalle, R. Al-Jehani, T. Diss, P. Munson, Hongxiang Liu, M. Du, P. Isaacson, A. Dogan (2002)
Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10.Blood, 99 2
百都亜矢子, 瀧澤淳, 東村益孝, 桃井明仁, 高橋英伸, 増子正義, 青木定夫, 相沢義房, 丸山聡一, 中村直哉 (2006)
当科におけるAngioimmunoblastic T‐cell Lymphoma(AIL‐T)の臨床的解析, 47
J. Dupuis, K. Boyé, N. Martin, C. Copie-Bergman, A. Plonquet, B. Fabiani, A. Baglin, C. Haioun, M. Delfau-Larue, P. Gaulard (2006)
Expression of CXCL13 by Neoplastic Cells in Angioimmunoblastic T-Cell Lymphoma (AITL): A New Diagnostic Marker Providing Evidence That AITL Derives From Follicular Helper T CellsThe American Journal of Surgical Pathology, 30
G. Frizzera, E. Moran, H. Rappaport (1974)
Angio-immunoblastic lymphadenopathy with dysproteinaemia.Lancet, 1 7866
L. Leval, C. Gisselbrecht, P. Gaulard (2010)
Advances in the understanding and management of angioimmunoblastic T‐cell lymphomaBritish Journal of Haematology, 148
E. Iannitto, A. Ferreri, V. Minardi, C. Tripodo, H. Kreipe (2008)
Angioimmunoblastic T-cell lymphoma.Critical reviews in oncology/hematology, 68 3
G. Pangalis, Edgar Moran, Bharat Nathwani, Ronald Zelman, Hun Kim, H. Rappaport (1983)
Angioimmunoblastic lymphadenopathy long‐term follow‐up studyCancer, 52
白神, 片岡 孝一, 藤井 幹雄, 河内 康憲, 井口 敬一, 田村 隆一, 宮本 弘, 小阪 昌明, 沼田 幸子, 三好 和夫 (1981)
56 珪肺症に発症したangio-immunoblastic lymphadenopathyとT cell lymphoma(職業アレルギー)Japanese Journal of Allergology, 30
M. Rodríguez-Justo, A. Attygalle, P. Munson, G. Roncador, T. Marafioti, M. Piris (2009)
Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres: a neoplasia with origin in the outer zone of the germinal centre? Clinicopathological and immunohistochemical study of 10 cases with follicular T-cell markersModern Pathology, 22
F. Lachenal, F. Berger, H. Ghesquières, P. Biron, A. Hot, E. Callet‐Bauchu, C. Chassagne, B. Coiffier, I. Durieu, H. Rousset, G. Salles (2007)
Angioimmunoblastic T-Cell Lymphoma: Clinical and Laboratory Features at Diagnosis in 77 PatientsMedicine, 86
K. Dunleavy, W. Wilson, E. Jaffe (2007)
Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implicationsCurrent Opinion in Hematology, 14
Abstract Angioimmunoblastic T cell lymphoma (AITL) is a peripheral T cell non-Hodgkin lymphoma with an aggressive fatal course and it has varied clinical presentation with an uncommon presentation when they present as soft tissue masses or when there is spill in the peripheral blood or there are composite lymphomas that are rare presentations. Common presentations include lymphadenopathy, fever and systemic symptoms, hemolytic anemias, skin rashes, and rheumatoid arthritis. The classical histopathology is absence of follicles in lymph nodes with presence of high endothelial venules and the tumor cells of small to medium-sized lymphocytes with pale cytoplasm mixed with reactive T cells. On immunohistochemistry, the cells are positive for CD3, CD4, CD10, BCL2, and CXCL13. In this observational study, the clinicopathologic presentation and the immunohistochemical profile of five cases who initially presented with a soft tissue mass which is an extremely rare presentation of this rare type of non-Hodgkin lymphoma that was diagnosed at our center with peripheral blood and bone marrow involvement and the clinicopathologic presentation, immunohistochemical profile, and response to treatment on follow-up are correlated with the literature review. One case had a fulminant and aggressive course and was fatal within 2 months of diagnosis. The rest of the four cases are on regular chemotherapy and follow-up. Our five cases had presented with soft tissue masses, two in the axillary regio,n two in the hand, and one in the scapular region with an extranodal presentation, and there was associated lymphadenopathy which developed subsequently with classic histomorphology and immunohistochemical findings. The age range was 46–54 years and all five cases were males. Three cases were with anemia (hemoglobin range 6.5–8.0 mg/dl) and all five cases were having peripheral blood plasmacytosis. Histopathology was classic with paracortical involvement with polymorphous population of cells with neoplastic lymphocytes of small and large sizes with numerous arborizing blood vessels which correspond to high endothelial venules. Microscopically, three architectural patterns; pattern I was seen in three cases (60%) and then pattern II and III in one case each (20% each). Immunohistochemistry revealed CD4+, CD8−, CXCL13+, CD10+, BCL6+, CD19, CD20, CD1a, Tdt, CD21, and CD23+ in follicular dendritic cells. AITL is a rare and aggressive non-Hodgkin lymphoma with varied clinical presentation with classic histomorphology with various patterns which may cause diagnostic dilemma and immunophenotypic findings, and prompt and early diagnosis is mandatory for institution of therapy.
Indian Journal of Surgical Oncology – Springer Journals
Published: Mar 1, 2018
Keywords: surgical oncology; oncology; surgery
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.